Patent · US Active

Binding assay for the diagnosis of a heparin-induced thrombocytopenia

US11320439B2 · kind B2 · utility

0Cited by

3References

12Claims

0Family size

Assignee

Siemens Healthcare Diagnostics Products GmbH · DE

Inventors

Harald Althaus · Wetter, DE
Herbert Schwarz · Niedereschach, DE
Norbert Zander · Marburg, DE

Key dates

Filing date	Jul 27, 2018
Grant date	May 3, 2022
Priority date	—
Expiry date	Oct 29, 2039

Classification

Technology area (CPC G)Physics
CPC primaryG01N2800/226
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

The present disclosure is in the field of in vitro diagnostics and relates to an easily automatable binding assay for establishing a heparin-induced thrombocytopenia, which binding assay uses FcγRIIa protein-coated particles.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.